ALLAN C SILBER
CIK 1009161 · Executive Chairman · last filed 2023-12-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.39M
Companies
3
Total Filings
35
Lifetime Open-Market Net
-$2.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| POINT Biopharma Global Inc. (PNT) Delisted | Executive Chairman | 4,268,605 | $12.50 | $53.36M | $311.2K | 5 | 2023-12-27 |
| HGBL | 10%+ Owner | 3,598,215 | $1.22 | $4.39M | -$2.51M | 7 | 2021-09-03 |
| POINT Biopharma Global Inc. (RACA) Delisted | Director | 8,254,260 | $10.27 | $84.81M | $0 | 1 | 2021-06-30 |
Recent Filings · Page 3 of 4
35 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-01 | — | Buy (P) | +155,000 | $55.8K | |
| 2014-12-16 | — | Buy (P) | +287,000 | $100.5K | |
| 2012-12-31 | — | Buy (P) | +12,888 | $14.2K | |
| 2012-12-26 | — | Buy (P) | +2,253 | $2.5K | |
| 2012-12-21 | — | Buy (P) | +1,085 | $1.2K | |
| 2012-12-17 | — | Buy (P) | +29 | $32 | |
| 2012-10-01 | — | Buy (P) | +13 | $18 | |
| 2012-09-25 | — | Buy (P) | +48 | $65 | |
| 2012-09-19 | — | Buy (P) | +68 | $92 | |
| 2012-09-17 | — | Buy (P) | +1,008 | $1.4K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.